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A B S T R A C T
Understanding the mechanism of action of the yessotoxin (YTX) is crucial since this drug has potential
pharmacological effects in allergic processes, tumor proliferation and neurodegenerative diseases. It has
been described that YTX activates apoptosis after 24h of treatment, while after 48h of incubation with
the toxin a decrease in cell viability corresponding to cellular differentiation or non-apoptotic cell death
was observed. In this paper, these processes were extensively studied by using the erythroleukemia K-
562 cell line. On one hand, events of K-562 cell differentiation into erythrocytes after YTX treatmentwere
studied using hemin as positive control of cell differentiation. Cell differentiation was studied through
the cyclic nucleotide response element binding (phospho-CREB) and the transferrin receptor (TfR)
expression. On the other hand, using rapamycin as positive control, autophagic hallmarks, as non-
apoptotic cell death, were studied after toxin exposure. In this case, the mechanistic target of rapamycin
(mTOR) and light chain 3B (LC3B) levels were measured to check autophagy activation. The results
showed that cell differentiation was not occurring after 48h of toxin incubation while at this time the
autophagy was triggered. Furthermore after 24h of toxin treatment none of these processes were
activated. In addition, the role of the type 4A phosphodiesterase (PDE4A), the intracellular target of YTX,
was checked. PDE4A-silencing experiments showed different regulation steps of PDE4A in the
autophagic processes triggered either by traditional compounds or YTX. In summary, after 48h YTX
treatment PDE4A-dependent autophagy, as non-apoptotic programmed cell death, is activated.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Yessotoxins (YTXs) are marine toxins produced by the dino-
ﬂagellates Protoceratium reticulatum,Lingulodinium polyedrum and
Gonyaulax spinifera (Satake et al., 1997). These phycotoxins were
originally isolated from the digestive gland of scallops Patinopecten
yessoensis (Murata et al., 1987). Phosphodiesterases (PDEs) were
described as the YTX target (Alfonso et al., 2003, 2005). In K-
562 cells, after the treatmentwith YTX, themitochondrial complex
A-kinase anchoring protein 149 (AKAP 149)-protein kinase A
(PKA)-type 4A PDE (PDE4A) migrates from the mitochondria to
plasma membrane and then to the nuclear envelope (Fernández-
Araujo et al., 2014). The localization of the complex is involved in
the decrease of cell viability observed after toxin treatment. In this
sense, apoptosis is triggered when the complex is located in the
plasma membrane. However, when the complex is located in the
nuclear envelope, a different pathway leading to cell viability
decrease is activated (Fernández-Araujo et al., 2014).
The erythroleukemia K-562 cell line is an undifferentiated
lineage that can be differentiated to various blood cell types after
several stimuli (Tsiftsoglou et al., 2003). This cell line is typically
differentiated into megakaryocyte or erythrocyte lineage (Huang
et al., 2011; Osti et al., 1997). In this sense, the increment in cAMP
levels was related with cellular differentiation in different cellular
lines (Copsel et al., 2011; Vassaux et al., 1992). In the nucleus, the
catalytic portions of the protein kinases such as PKA or mitogen-
activated protein kinases (MAPK), can phosphorylate the cAMP
response element binding (CREB) (Shaywitz and Greenberg, 1999).
The active form of CREB, phospho-CREB, is a transcription factor
that begins to traduce new genes to cellular differentiation
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(Pellegrini et al., 2008). In the myeloid leukemia K-562 cell line,
also called erythroleukemia cell line, the transcription factor
phospho-CREB activates the erythroid differentiation (Di Pietro
et al., 2007). In this sense, the transferrin receptor CD71 (TfR), is
described as the erythroid precursor marker, and its levels
decrease in mature erythrocytes (Marsee et al., 2010). The TfR is
overexpressed in several types of tumor cell lines (Gatter et al.,
1983; Ryschich et al., 2004). This transmembrane glycoprotein,
CD71, is responsible for the iron uptake from the extracellular
medium into the cytosol playing a key role in K-562 metabolism
(Bottomleyet al.,1985; Daniels et al., 2006). In addition, the CD71 is
related with the activation of apoptotic cell death after its
internalization-inhibition independently of iron availability
(Kasibhatla et al., 2005). A prolonged CD71 internalization
inhibition, leads to a decrease in cell iron uptake (Ponkaa and
Lok, 1999). Under low iron availability, the cell activates the
recycling pathways to obtain the metal from iron-rich organelles
and macromolecules through the activation of autophagy (Kurz
et al., 2008). This mechanism, is a survival strategy to obtain basic
elements when cells have deﬁcit in nutrients. Also it is responsible
for the turnover and reutilization of damaged proteins and
organelles, but can degenerate into autophagic cell death (Codogno
and Meijer, 2005; Kurz et al., 2011). Autophagy involves the
sequestration of damaged organelles and proteins in double-
membrane vacuoles called autophagosomes. These vacuoles fuse
with lysosomes to form autolysosomes to degrade the material
leaving available nutrients to cell growth (Codogno and Meijer,
2005; Stern et al., 2012). Mechanistic target of rapamycin (mTOR)
has a key role in autophagy activation since under normal
conditions this protein is phosphorylated (phospho-mTOR) and
inhibits the autophagy. However, after nutrients deprivation or
rapamycin treatment, the phosphorylation of mTOR is inhibited
and this protein turns in the inactive form, hence triggering
autophagy (Codogno and Meijer, 2005; Klionsky and Emr, 2000;
Stern et al., 2012). Autophagosomes, that sequestered different
parts of the cells, are covered by the light chain 3 (LC3) protein
(Codogno andMeijer, 2005; Stern et al., 2012). There are 3 isoforms
of LC3 protein in mammals: LC3A, LC3B and LC3C (Lazova et al.,
2012). LC3 is synthesized as the cytosolic form of LC3-I to then
form the LC3-II protein bound to the lipid membranes of the
autophagosomes (Lazova et al., 2012). Therefore, mTOR and
LC3 proteins are essential in autophagic processes. In this context,
the aim of this work was to elucidate the pathways involved in the
decrease of cell viability observed after 48h of incubation with
YTX. In addition, the role of PDE4A in the processes activated was
further checked.
2. Materials and methods
2.1. Reagents and solutions
YTX was from CIFGA Laboratories (Lugo, Spain). Anti-b-tubulin
I, bovine serum albumin (BSA), CaCl2, NaH2PO4, trizma hydrochlo-
ride, Triton X-100, glycine, trizma base, SDS (sodium dodecyl
sulphate), hemin and Tween1 20 were from Sigma–Aldrich
(Madrid, Spain). NaCl, MgSO4, NaHCO3 and glucose were from
Panreac (Barcelona, Spain). Anti-LC3B (light chain 3), anti-PDE4A,
anti-VDAC1 (voltage-dependent anion channel 1) and rapamycin
were from ABCAM (CA, USA). Anti-histone 1, anti-b-actin, anti-
phospho-mTOR, polyvinylidene ﬂuoride (PVDF) membrane and
goat anti-rabbit IgG peroxidase conjugated were from Millipore
(Termecula, USA). Anti-phospho-CREB pSer133 was from Immuno-
step (Salamanca, Spain). Anti-mouse IgG horseradish peroxidase-
linked species-speciﬁc whole antibody was from GE Healthcare
(Barcelona, Spain). Anti-CD71 phycoerythrin conjugated (anti-PE-
CD71) and PDE4A siRNA (human) were from Santa Cruz
Biotechnology (California, USA).
Polyacrylamide gels and molecular weight marker Precision
Plus ProteinTM Standards KaleidoscopeTM were purchased from
BioRad1 (Barcelona, Spain). Protease inhibitor complete tablets
and phosphatase inhibitor cocktail tablets were from Roche
(Madrid, Spain). Free calcium and magnesium PBS used in ﬂow
cytometry assays were purchased from Gibco, Life Technologies
(Madrid, Spain).
Physiological saline solution composition was (in mM): Na+
142.3, K+ 5.94, Ca2+ 1, Mg2+ 1.2, Cl 126.2, HCO3 22.85, HPO42 1.2,
and SO42 1.2; glucose 1 g/l was added to the medium giving an
osmotic pressure of 29010mOsm/kg of H2O and pH was
adjusted to 7.2 with HCl 0.1N from Panreac (Barcelona, Spain),
and CO2. PBS used to wash the western blotting membranes
consisted of NaCl 137mM, Na2HPO4 10.14mM, KH2PO4 1.76mM,
and KCl 2.68mM; pH was adjusted to 7.2 with NaOH.
2.2. Cell culture
K-562 cell line was from the National Cancer Institute (NCI) and
maintained in the Roswell Park Memorial Institute 1640 (RPMI
1640) medium supplemented with 10% fetal bovine serum (FBS)
and 50units/ml penicillin and 50mg/ml streptomycin. All these
reagents were from Gibco, Life Technologies (Madrid, Spain). Cells
were growing at 37 C in a humidiﬁed 5% CO2 atmosphere.
Incubations with 30nM YTX were carried out under these
conditions of temperature, humidity and percentage of CO2.
2.3. Subcellular fractionation
3106 cells per conditionwere incubated 24 and 48h with and
without 30nM YTX and cytosolic and nuclear fractions were
obtained as explained before (Fernández-Araujo et al., 2014).
2.4. Western blotting analysis
Bradford from BioRad1 (Barcelona, Spain) assay and the direct
detect spectrometer fromMillipore (Termecula, USA) were used to
know sample protein concentration and BSA was used as protein
standard. The different subcellular fractions were blotted to PVDF
membrane by reduced SDS-PAGE. To determine the protein size
and also to monitor the progress of electrophoretic runs, Precision
Plus ProteinTM Standards KaleidoscopeTM molecular weight
marker was used. After blockage with 0.5% BSA the membranes
were incubated 10minwith anti-phospho-CREB pSer133, anti-LC3B
and anti-phospho-mTOR, then were washed three times with PBS
and 0.1% Tween1 20 and incubated for 10minwith secondary anti-
mouse IgG horseradish peroxidase-linked species-speciﬁc whole
antibody. After three washes, chemiluminescence was visualized
with SuperSignal1 West Pico (low intensity) (ThermoScientiﬁc,
34080), with SuperSignal1West Femto (high intensity) (Thermo-
Scientiﬁc, 34095), or with ClarityTM western ECL substrate
(BioRad1). The chemiluminiscent signal was detected with the
diversity GeneSnap software and analyzed by the diversity 4 gel
documentation and analysis system. Relative protein expression
was calculated in relation to b-actin expression for each
experiment in cytosolic fraction and with histone 1 in nuclear
fraction (Tobío et al., 2011). Experiments were carried out at least
three times by duplicate. The subcellular fraction purity was tested
by measuring control proteins of each fraction: VDAC1/porin
protein is present in the mitochondrial membrane and in plasma
membrane. VDAC1was positive in cytoplasm fraction that includes
the mitochondrial portion. Histone 1 was only present in the
nuclear fraction. And b-tubulin is located in both cytosol and
nuclear fraction (Lawen et al., 2005; Walss et al., 1999).
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2.5. Flow cytometry assay and K-562 differentiation
2106 cells per condition were incubated for 24 and 48h with
and without 30nM YTX. Under the same conditions, cells were
incubated with 40mM hemin. Then, cells were washed twice with
saline solution and ﬁxed with 4% paraformaldehyde (PFA)
(Electron Microscopy Sciences) for 20min at 4 C. Cells were
centrifuged andwashedwith 500ml of PBSwith 1mMCaCl2. Then,
the cells were centrifuged and permeabilized by incubating on ice
for 10min with PBS – 5%, BSA – 0.1% Triton X-100. The cells were
thenwashed twice with PBS, followed by the incubationwith anti-
PE-CD71 in a 1:100 dilution for 30min at 37 C in darkness. Finally,
the cells were washed twice with PBS and resuspended in a ﬁnal
volume of 100ml of PBS pH 7.2 and analyzed by ﬂow cytometry
technique. The data obtained from the measurement of the
ﬂuorescence intensity were analyzed by the IDEAS 4.0 cell image
analysis software.
2.6. Transfection by lipid-based method (Genlantis)
GeneSilencer1 solutions form Genlantis (San Diego, USA) were
prepared as described before (Tobío et al., 2013). 1.2106 cells
were incubated in a total volume of 500ml of RPMI 1640 medium
with GeneSilencer1 solutions and after 5h of transfection 500ml
of RPMI 1640 was added and 19h later the cells were treated with
30nM YTX and 80nM rapamycin in each case for 24 and 48h.
Control siRNA from Santa Cruz was used as negative control for
evaluating RNAi off-target effects.
2.7. Statistical analysis
All the experiments were carried out at least three times by
duplicate. Student's t-test and ANOVA were used to examine
statistical signiﬁcance, assumed for p<0.05. Results were
expressed as the means SEM.
3. Results
Previous studies have shown the cytotoxic effect of YTX in K-
562 cell line. Cells treatedwith YTX for 24 and 48h decreased their
viability (Tobío et al., 2012). After 24h of YTX treatment, the
apoptotic programmed cell death was activated, while after 48h
apoptotic hallmarks were not detected. At this time, the complex
AKAP 149-PKA-PDE4A was located in the nuclear envelope
(Fernández-Araujo et al., 2014). There, C subunits of PKA can
diffuse through the nuclear envelope after its activation and
phosphorylate the transcription factor CREB (Harootunian et al.,
1993; Sample et al., 2012). Therefore, in this context, the levels of
phospho-CREB were checked. Fig. 1 shows the phosphorylated
CREB levels after 48h in the presence of YTX. Under these
conditions, the nuclear expression of active CREB signiﬁcantly
increased 15% (Fig. 1A), suggesting K-562 cell differentiation
probably into erythrocytes (Mei et al., 2013). Hemin has been
described as a potent K-562 cell line differentiation inductor into
erythrocytes, through the decrease of CD71 levels in the plasma
membrane (Honma et al., 1989; Rowley et al., 1981; Wu et al.,
2011). Therefore, CD71 expression was measured in the K-
562 cellular cover by ﬂow cytometry after YTX treatment and
compared to hemin-treated cells. Fig. 2 shows the CD71 expression
in the K-562 plasmamembrane after 24 and 48h of treatmentwith
YTX and hemin. Fig. 2A–F shows representative images of cells in
brightﬁeld (channel 05) and phycoerythrin (PE) intensity channels
(channel 04). The percentage of phycoerythrin-CD71 (PE-CD71)
intensity was obtained from histograms generated by IDEAS 4.0
cell image analysis software (Fig. 2A–F). The diagrams generated by
the software represent in the X axis the PE intensity and in Y axis
the cellular population. The displacement of the histogram to the
right implies higher PE intensities and subsequent more levels of
the CD71 in the cell membrane. Fig. 2A–C shows the cell images
and histograms of PE-CD71 intensity in untreated, hemin- and
YTX-treated cells, respectively after 24h while in Fig. 2D–F, 48h
[(Fig._1)TD$FIG]
Fig.1. Effect of YTX on nuclear phospho-CREB expression in human K-562 cell line. (A): Percentage of nuclear phospho-CREB levels in K-562 cell line after the incubationwith
30nM YTX for 48h (37 C, 5% CO2 atmosphere). Mean SEM of three experiments. Nuclear phospho-CREB values were calculated with respect to histone-1 band intensity.
10106 cells per conditionwere lysed and 20mg of total protein per conditionwas charged in the electrophoresis gel. (*) Signiﬁcant differences between untreated and YTX-
treated cells. (B): Representative experiment after 48h of incubation. (C): Representative proteins as positive and negative controls of the nuclear fraction purity.
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[(Fig._2)TD$FIG]
Fig. 2. Effect of YTX on plasma membrane levels of CD71 receptor in K-562 cell line: representative cellular images and histograms of the CD71 expression in control cells,
hemin- and YTX-treated cells after 24h (A, B, C, respectively) and after 48h (D, E, F, respectively) of incubation. Brightﬁeld images are represented in channel 05 and PE
intensity images are shown in channel 04. (G): Percentage of cells with CD71 expression in plasma membrane after YTX treatment. Open bars: 40mM hemin-treated cells
after 24 (on the left) and 48h (on the right). Black bars: 30nM YTX-treated cells after 24 (on the left) and 48h (on the right). Data referred to untreated cells. Mean SEM of
three experiments (5000 cells were analyzed in each experiment). (*) Signiﬁcant differences between untreated and hemin- and YTX-treated cells.
A. Fernández-Araujo et al. / Toxicology 329 (2015) 60–72 63
[(Fig._3)TD$FIG]
Fig. 3. Effect of YTX on cytosolic phospho-mTOR expression in human K-562 cell line. (A) and (C): Percentage of cytosolic phospho-mTOR levels in K-562 cell line after the
incubationwith 30nMYTX, 80nM rapamycin, and co-incubation of both for 24 and 48h, respectively (37 C, 5% CO2 atmosphere).Mean SEMof three experiments. Cytosolic
phospho-mTOR values were calculated with respect to b-actin band intensity. 4106 cells per condition were lysed and 20mg of total protein per condition was charged in
the electrophoresis gel. (*) Signiﬁcant differences between untreated and YTX- and rapamycin-treated cells. (B) and (D): Representative experiments after 24 and 48h of
incubation, respectively. (E): Representative proteins as positive and negative controls of the cytosolic fraction purity.
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[(Fig._4)TD$FIG]
Fig. 4. Effect of YTX on cytosolic LC3B-II/LC3B-I expression in human K-562 cell line. (A) and (C): Percentage of cytosolic LC3B-II/LC3B-I levels in K-562 cell line after the
incubation with 30nM YTX and 80nM rapamycin for 24 and 48h, respectively (37 C, 5% CO2 atmosphere). Mean SEM of three experiments. Cytosolic LC3B-I and LC3B-II
values were calculated with respect to b-actin band intensity and the ratio between LC3B-II and LC3B-I was calculated in order to quantify the autophagosomal LC3B-II
isotype. 4106 cells per conditionwere lysed and 20mg of total proteinper conditionwas charged in the electrophoresis gel. (*) Signiﬁcant differences betweenuntreated and
YTX- and rapamycin-treated cells. (B) and (D): Representative experiment after 24 and 48h of incubation, respectively. (E): Representative proteins as positive and negative
controls of the cytosolic fraction purity.
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treatments are shown. In hemin-treated cells, a displacement of
the histograms toward the left with respect to untreated cells was
observed; however, in YTX-treated cells higher percentage of PE-
CD71 intensity was shown by the displacement of the histogram
toward the right. Fig. 2G summarizes these results. Opposite
effects were observed after YTX or hemin exposition. Hemin
decreased 7% and 10% CD71 expression after 24 and 48h,
respectively, while its expression was 18% and 10% enhanced after
24 and 48h of YTX incubation, respectively. Therefore, considering
these results, K-562 cell differentiation into erythrocytes was not
activated by the treatmentwith the toxin. Since differentiationwas
not occurring, other types of cell death were then checked. In this
sense, the increased levels of the TfR after YTX exposure could be
related with a deﬁcit trafﬁcking of CD71 toward the cytosol. In
addition, CD71 internalization inhibition leads to a decrease in cell
iron uptake, which can induce autophagy activation by nutrients
deprivation (Klionsky and Emr, 2000; Kurz et al., 2008; Ponkaa and
Lok, 1999). So, different autophagic hallmarks were checked after
24 and 48h of YTX incubation by using rapamycin as positive
control (Codogno andMeijer, 2005; Khan et al., 2012; Klionsky and
Emr, 2000). Fig. 3 shows the phospho-mTOR protein expression
after 24 and 48h of YTX incubation. No differences were found in
phospho-mTOR levels compared to untreated K-562 cell line after
24h of YTX incubation (Fig. 3A). Nevertheless the levels of protein
were signiﬁcantly decreased, 41% and 33%, after rapamycin or co-
incubation of YTX and rapamycin, respectively (Fig. 3A). However,
after 48h of treatment, YTX signiﬁcantly decreased by 56% the
phospho-mTORexpression (Fig. 3C). In the sameway protein levels
were signiﬁcantly decreased, 85% and 66%, after rapamycin and
YTX-rapamycin treatments, respectively (Fig. 3C). Therefore, the
results point to the activation of autophagic cell death only after
48h but not after 24h of the toxin incubation. In order to clarify if
the whole autophagic process is taking place, LC3B protein was
checked. This molecule is usually located in cytosol under a 18kDa
LC3-I isoform, that is post-translationally modiﬁed into the 16kDa
LC3B-II isoform bound to the autophagosome envelope after
autophagy activation (Wu et al., 2006). Fig. 4 shows LC3B-II/LC3B-I
ratio levels after incubationwith YTX and rapamycin. Surprisingly,
after 24h of YTX treatment, a signiﬁcant LC3B-II/LC3B-I increment
of 148% was observed while in the presence of rapamycin only 44%
of LC3B-II/LC3B-I expression increase was shown (Fig. 4A). After
48h of YTX and rapamycin treatments, the LC3B-II/LC3B-I levels
were 208% and 97% increased, respectively (Fig. 4C).
The protein PDE4A has a crucial role in those pathways
activated by YTX in the K-562 cell line. Previous studies have
shown that mitochondrial complex AKAP 149–PKA–PDE4A migra-
tion from the cytosol was avoided after YTX treatment in PDE4A-
silenced K-562 cells and as consequence K-562 cell death was
inhibited (Fernández-Araujo et al., 2014). Therefore, autophagy
hallmarks were studied after toxin exposition of PDE4A-silenced
K-562 cells. Fig. 5 shows the effectiveness of lipid-based
transfection method of PDE4A-silencing. As Fig. 5A represents, a
decrease of 50% and 55% in PDE4A expression was observed after
48 and 72h of transfection, respectively. Next, the autophagic
hallmarks were checked in the PDE4A-silenced K-562 population
after 24 and 48h of YTX and rapamycin treatments. As Fig. 6 shows,
in PDE4A-silenced cells no changes were observed in phospho-
mTOR expression after 24h of YTX exposure while a decrease of
60%, similar to untransfected cells, was detected in rapamycin 24h
treated cells (Fig. 6A). Fig. 6D shows the expression of mTOR
phosphorylated in PDE4A-silenced cells after 48h compounds
exposure. Rapamycin incubation signiﬁcantly decreased phospho-
mTOR expression either in control and PDE4A-silenced popula-
tions, 85% and 72%, respectively. However, no changes in the
phospho-mTOR levels were observed after YTX treatment
(Fig. 6D). In addition, LC3B-I and LC3B-II expression were studied
in PDE4A-silenced population (Fig. 7). After 24 or 48h of YTX
treatment, signiﬁcant increases in LC3B-II/LC3B-I ratio were
[(Fig._5)TD$FIG]
Fig. 5. Determination of PDE4A silencing efﬁciency bywestern blotting analysis in K-562 cell line. (A): Percentage of cytosolic PDE4A levels in K-562 cell line after 48 and 72h
of PDE4A siRNA transfection (37 C, 5% CO2 atmosphere). Mean SEM of three experiments. Cytosolic PDE4A values were calculated with respect to b-actin band intensity.
4106 cells per conditionwere treated and 20mg of total protein per conditionwas charged in the electrophoresis gel. (*) Signiﬁcant differences between untransfected and
siPDE4A transfected K-562 cell line. (B) and (C): Representative experiment after 48 and 72h of PDE4A-silenced K-562 cell line, respectively. (D): Representative proteins as
positive and negative controls of the cytosolic fraction purity.
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[(Fig._6)TD$FIG]
Fig. 6. Effect of YTX on cytosolic phospho-mTOR expression in PDE4A-silenced K-562 cell line. Cells were ﬁrst incubated with the PDE4A siRNA for 24h and then for 24 and
48h plus with 30nMYTX and 80nM rapamycin (37 C and 5% CO2 atmosphere). (A) and (D): Percentage of cytosolic phospho-mTOR levels in K-562 cell line after 24 and 48h,
respectively. Mean SEM of three experiments. Cytosolic phospho-mTOR valueswere calculatedwith respect tob-actin band intensity. 4106 cells per conditionwere lysed
and 20mg of total protein per condition was charged in the electrophoresis gel. (*) Signiﬁcant differences between untreated and YTX- and rapamycin-treated cells. (B) and
(C): Representative experiment of western blot band intensity of cytosolic phospho-mTOR in untrasnfected and PDE4A-silenced cells, respectively after 24h of treatment. (E)
and (F): Representative experiment of western blot band intensity of cytosolic phospho-mTOR in untrasnfected and PDE4A-silenced cells, respectively after 48h of treatment.
(G): Representative proteins as positive and negative controls of cytosolic fraction purity.
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[(Fig._7)TD$FIG]
Fig. 7. EffectofYTXoncytosolicLC3B-II/LC3B-I expression inPDE4A-silencedK-562cell line. Cellswereﬁrst incubatedwith thePDE4AsiRNAfor24handthen for24and48hpluswith
30nMYTXand80nMrapamycin (37 Cand5%CO2atmosphere). (A)and(D):PercentageofcytosolicLC3B-II/LC3B-I levels inK-562cell line.Mean SEMof threeexperiments.Cytosolic
LC3B-IandLC3B-IIvalueswerecalculatedwithrespect tob-actinbandintensityandtheratiobetweenLC3B-II andLC3B-Iwascalculated inorder toquantify theautophagosomalLC3B-
II isotype. 4106 cells per conditionwere lysed and 20mg of total protein per conditionwas charged in the electrophoresis gel. (*) Signiﬁcant differences between untreated andYTX-
and rapamycin-treated cells. (B) and (C): Representative experiment ofwestern blot bands intensity of cytosolic LC3B-II/LC3B-I expression in untrasnfected and PDE4A-silenced cells,
respectivelyafter 24hof treatment. (E) and (F): Representative experimentofwesternblot bands intensityof cytosolic LC3B-II/LC3B-I expression inuntrasnfectedandPDE4A-silenced
cells, respectively after 48h of treatment. (D): Representative proteins as positive and negative controls of cytosolic fraction purity.
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observed either in control and in PDE4A-silenced populations,
148% versus 212% and 208% versus 448%, respectively (Fig. 7A and
D). However, in these conditions a high inhibition was observed in
the presence of rapamycin. After 24 or 48h of rapamycin
incubation a signiﬁcant increase, 43% and 97%, of LC3B-II/LC3B-I
expression was observed in control cells, while in PDE4A-silenced
cells no changes in protein ratio levels were obtained. Therefore,
after YTX treatment autophagy hallmarks were activated in a
PDE4A dependent manner. In addition an important interaction
between PDE4A and LC3B protein was shown after PDE4A-
silencing cells were treated with rapamycin, while in these cells
YTX treatment increases LC3B-II expression in a PDE4A-indepen-
dent manner.
4. Discussion
Recent studies have shown a K-562 cell viability decrease after
long-term incubations with YTX. Treatment for 24h with the toxin
triggered apoptosis, while a non-apoptotic pathway was taking
over after 48h of toxin exposure keeping the viability down. At this
time, increased levels of AKAP 149–PKA–PDE4A complex were
measured in the nucleus (Fernández-Araujo et al., 2014). Different
theories can be pointed out to explain this situation. In the nuclear
envelop, the catalytic subunits of PKA anchored to AKAP 149 can be
translocated into the nucleus and there CREB protein can be
phosphorylated. The phosphorylated CREB can activate K-562 cell
line differentiation into erythrocytes, leading to a cell viability
decrease through the fall in cell proliferation rate (Di Pietro et al.,
2007; Harootunian et al., 1993; Ren et al., 2010). Since increased
levels of phosphorylated CREB after 48h of YTX treatment were
observed, another speciﬁc K-562 cell differentiation marker was
studied. In this manner, the CD71 is often overexpressed in cells
with high proliferation rate, in tumor cells and in erythroid
precursors (Daniels et al., 2006; Marsee et al., 2010). Also, it was
described that K-562 cell differentiation to erythrocytes after
hemin incubation was associated to the decrease of receptor
CD71 expression in the cell plasmamembrane (Marsee et al., 2010;
Wu et al., 2011). However, YTX treatment signiﬁcantly increased
CD71 expression after 24 and 48h incubation, opposite to hemin
effects. Therefore, YTX did not induce K-562 cell differentiation.
Furthermore, the increment of CD71 levels in the plasma
membrane can be due to the inhibition of receptor internalization
(Daniels et al., 2006). In this sense, the high levels of PKA observed
in the plasma membrane after 24h of toxin incubation before
described, could be related with the CD71 internalization inhibi-
tion, since that protein is involved in endocytotic events
(Fernández-Araujo et al., 2014; Salazar and Gonzalez, 2002). In
addition, the inhibition is also related with the apoptosis activated
in the ﬁrst 24h, as it was described after gambogic acid treatment
of different tumor cell lines (Kasibhatla et al., 2005). The effect of
gambogic acid was also mediated by the activation of mitochon-
drial apoptosis (Yang et al., 2007). So the mitochondrial apoptotic
pathway and the internalization inhibition of CD71 receptor can be
connected through several pathways (Kotamraju et al., 2002;
Tampo et al., 2003). Moreover, after 24h of YTX treatment, no
modiﬁcation in the autophagic protein phospho-mTOR levels was
observed, pointing to apoptosis as the main programmed cell
death activated by the toxin at this time, as it was described before
(Fernández-Araujo et al., 2014). At this time, the levels of LC3B-II
protein were signiﬁcantly increased by YTX as well as by the
positive autophagic control, rapamycin. Although LC3B-II is
intimately associated to autophagic processes (Wu et al., 2006),
the higher levels of this protein detected in the ﬁrst 24h of YTX
treatment can be related with apoptosis. LC3B protein has been
described in the activation of extrinsic apoptotic cell death after its
interaction with the extrinsic apoptotic factor Fas through the
caveolin-1 (Cav-1) protein (Chen et al., 2010). The increase in LC3B-
II levels obtained after 24h of YTX incubation, correlates with
caspase 8 activation observed in previous works (Fernández-
Araujo et al., 2014). When the cells were treated with YTX, no
external ligands activate death-inducing signaling complex (DISC)
that mediates the activation of procaspase 8 into caspase 8 after
the binding of the ligand to the complex (Korsnes and Espenes,
2011). Therefore, the activation of caspase 8 by YTX seems to take
place through the internal activation of Fas receptor and this could
be done by LC3B interactionwith Cav-1 (Chen et al., 2010). Besides
LC3B has a PKA phosphorylation site and through this phosphory-
lation the autophagy is inhibited (Cherra et al., 2010). Since after
24h of YTX incubation the cytosolic PKA levels were increased, the
interaction LC3B–PKA could be possible (Fernández-Araujo et al.,
2014). Interestingly, after 24h of treatment with YTX in PDE4A-
silenced population, LC3B-II levels remained increased showing
that LC3B-II increment was independent of PDE4A. Therefore, the
toxinwas activating other pathways independent of PDE4A, and in
addition other PDEs subtypes were involved in these processes.
However, PDE4A-silencing avoids the effect of rapamycin on LC3B-
II expression after 24h of incubation, pointing to the key role of
PDE4A in autophagy downstream of phospho-mTOR inhibition
and upstream of LC3B synthesis.
On the other hand, a decrease in the cytosolic phospho-mTOR
expression was shown after 48h of incubation with YTX,
accompanied by an increase in LC3B-II levels. Therefore, in these
conditions, autophagy activation could explain the cell viability
decrease observed. In addition, at this time the CD71 endocytosis
was still inhibited and as consequence a serious intracellular iron
deprivation was happening (Ponkaa and Lok, 1999). Therefore,
autophagy could be activated as cellular nutrients necessity
(Klionsky and Emr, 2000; Ohyashiki et al., 2009). It has been
described that YTX activates different types of programmed cell
death, and recently, the autophagy activation after the treatment
with this toxin was pointed in human glioma cells (Korsnes, 2012;
Rubiolo et al., 2014). Furthermore, previousworks have shown that
in the ﬁrst 24h of YTX exposure, caspase 8 was activated in K-562
cells, but after 48 h this activation disappears (Fernández-Araujo
et al., 2014). When this caspase was activated, autophagy was
blocked, while after 48h of toxin incubation caspase 8 was
returned to basal activity (Yu et al., 2004). Therefore, all these data
are in accordance with autophagy activation in K-562 after 48h of
YTX exposure. At this time of treatment, after 48h of incubation,
the activation of CREB proteinwas detected but the involvement of
this transcription factor with autophagy is not clear. Some authors
have described that formoterol activates CREB and acts on Akt-
mTOR pathway to ﬁnally increase the levels of LC3B, having a
connection between phospho-CREB and autophagy activation
(Joassard et al., 2013). Others have described that the anti-
apoptotic protein Bcl-2 inhibits beclin-1 and autophagy was
blocked. Bcl-2 is regulated by CREB, so that down-regulation of
CREB decreases Bcl-2 and autophagy is triggered (Jambal et al.,
2003; Wang et al., 2012). However, our results suggest that after
48h of YTX treatment autophagywas activated and phospho-CREB
levelswere increased, and no effect in Bcl-2 expression after 48h of
YTX treatment had been shown (Fernández-Araujo et al., 2014).
Therefore, the implication of the transcription factor, phospho-
CREB, in autophagy induced by YTX in K-562 cells, remains unclear
and the role of phospho-CREB in this pathway should be further
studied. The PDE4A-silencing results in autophagic proteins levels
were very intriguing. In autophagic cells incubated with rapamy-
cin, no interactions were observed between PDE4A and phospho-
mTOR proteins. However, after 48h of YTX treatment in PDE4A-
silenced population, phospho-mTOR protein levels returned to
untreated levels. Therefore, the autophagy activated by YTX is
dependent of PDE4A protein. However, LC3B-II levels were
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increased at this time by YTX in either untransfected or PDE4A-
silenced cells, suggesting an alternative pathway activated by YTX
independent of PDE4A to increase LC3B-II synthesis. But the
increment observed in LC3B-II at this time in PDE4A-silenced cells
did not induce cell death, since previous studies have shown cell
death inhibition after YTX treatment of PDE4A-silenced population
(Fernández-Araujo et al., 2014). On the other hand, the phospho-
mTOR inhibition by rapamycin in PDE4A-silenced cells, avoided
the LC3B-II synthesis as it was observed in the ﬁrst 24h, pointing to
PDE4A as a key protein in the conventional autophagic pathway.
Little is known about the PDEs implication in autophagic path-
ways. However, the subtype 4A4 of PDE (PDE4A4) has been
described and related to the autophagosomes production through
the interaction with the scaffold protein p62
(sequestosome1 SQSTM1), involved in autophagosomes formation
(Christian et al., 2010; Day et al., 2011; Pankiv et al., 2010). The
authors focused on the fact that rapamycin inhibits the PDE4A–
p62 aggregation by irreversibly sequestering the p62, lowering the
amount of free p62 to aggregate with PDE4A4 (Christian et al.,
2010). Other investigations have suggested that autophagy hall-
marks present in extensor digitorum longus (EDL) muscles of
fasted rats were decreased after rolipram treatment (Lira et al.,
2011). In the present paper, similar resultswere observed, since the
lack of PDE4A in PDE4A-silenced cells, avoids the YTX effect on the
autophagic hallmark phospho-mTOR. Furthermore, previous
studies have shown that after 48h of YTX exposure, the AKAP
149–PKA–PDE4A complex was increased in the nuclear envelope
and after PDE4A-silencing, the complex was not translocated from
the cytoplasm (Fernández-Araujo et al., 2014). In addition, the
results of the present paper showed autophagy activation. Similar
effect after rapamycin treatment was described in SH-SY5Y. This
compound triggers the type IIa regulatory subunit of PKA (RIIa)
phosphorylation, to then activate the nuclear translocation of the C
subunit of PKA (Liu et al., 2013). So in K-562 cell line after 48h of
YTX treatment the autophagy can be activated through the
complex AKAP 149–PKA–PDE4A migration to the nucleus.
Moreover, other studies pointed to PKA as a modulator of mTOR
and autophagy (Mavrakis et al., 2006). The RIa of PKA is needed to
autophagy induction, since RIa-silenced cells decreased autoph-
agy and increased phospho-mTOR expression (Mavrakis et al.,
2006). Previous studies suggested that after 48h of YTX exposure,
cytosolic RIIa of PKA was increased in the nucleus, and in the
present paper autophagy was triggered, while after PDE4A-
silencing, RIIa expression was not changed in the cytosol and
autophagy was avoided (Fernández-Araujo et al., 2014). Therefore,
PKA could have a key role in autophagy after its activation and
translocation to the nucleus.
Fig. 8 summarizes in a visual scheme the type of cell death
pathways activated by YTX and the interaction between them.
Previous investigations about apoptotic pathway triggered by the
toxin in K-562 cells are also represented in the ﬁgure.
5. Conclusions
In summary, the results presented in this paper, elucidate the
autophagic cell death activated in K-562 by YTX after 48h of
incubation. Moreover, new theoretical activation of extrinsic
apoptotic cell death was pointed out after YTX treatment through
the cytosolic PKA, LC3B and the interaction of this proteinwith Fas
receptor activating caspase 8. On the other hand, autophagy
activation by the toxin points YTX as a potential pharmacological
compound against cancer disorders, since autophagy is becoming a
[(Fig._8)TD$FIG]
Fig. 8. Possible models activated after YTX incubation. Model of pathways activated after incubation with YTX for 24 and 48h. YTX binds to PDE4A in the AKAP 149–PKA–
PDE4A complex in the outer mitochondrial membrane. Black arrows: In the ﬁrst 24h, the complex migrates from the mitochondria to the plasma membrane,
CD71 internalization is avoided by PKA in the plasma membrane and LC3B expression is increased in the cytosol. PKA phosphorylates LC3B protein and the inactive form of
LC3B binds to DR through Cav-1 to trigger extrinsic apoptosis. Dotted arrows: After 48h of toxin incubation, the complexmigrates from the plasmamembrane to the nuclear
envelope and CREB is phosphorylated by the catalytic subunit of PKA. CD71 internalization remains avoided and as a consequence of prolonged iron deprivation, phopho-
mTOR decreased and LC3B increased leading to autophagy activation. White arrows: results of this paper. Grey arrows: info of other papers . (?) The transcription factor
phospho-CREB could activate the synthesis of genes involved in autophagy. R and C are subunits of PKA. CD71, transferrin receptor CD71; DR, death receptor; Cav-1, Caveolin-
1.
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therapy to tumor cells because it is a pathway typically altered in
this type of cells (Kimmelman, 2011; Kondo et al., 2005).
Furthermore, the involvement of PDE4A in rapamycin-activated
autophagywas demonstrated downstream ofmTOR inhibition and
upstream of LC3 production. Also the increased levels of LC3B-II in
PDE4A-silenced cells induced by YTX are independent of PDE4A
andmTOR.When PDE4A is not silenced, YTX triggers conventional
autophagy through mTOR that leads to autophagic cell death.
However, when the PDE4A is silenced, YTX increases the LC3B-II
expression through other pathway independent of phospho-mTOR
and autophagy survive could be activated.
Conﬂicts of interest
The authors declare that there are no conﬂicts of interest.
Transparency document
The Transparency document associated with this article can be
found in the online version.
Acknowledgements
The research leading to these results has received funding from
the following FEDER cofunded-grants: from CDTI and Technologi-
cal Funds, supported by Ministerio de Economía y Competitividad,
AGL2009-13581-C02-01, AGL2012-40185-CO2-01 and Consellería
de Cultura, Educación e Ordenación Universitaria, GRC2013-016,
and through Axencia Galega de Innovación, Spain, ITC-20133020
SINTOX, IN852A 2013/16-3 MYTIGAL, from CDTI under ISIP
Programme, Spain, IDI-20130304 APTAFOOD.
The research has also received funding from the European
Union’s Seventh Framework Programme managed by REA –
Research Executive Agency (FP7/2007-2013) under grant agree-
ment nos. 265409mAQUA, 315285 CIGUATOOLS and 312184 PHAR-
MASEA. Andrea Fernández Araujo is supported by a fellowship
from Subprograma de Formación de Personal Investigador
(AGL2009-13581-C02-01), Spain.
References
Alfonso, A., de la Rosa, L., Vieytes, M.R., Yasumoto, T., Botana, L.M., 2003. Yessotoxin,
a novel phycotoxin, activates phosphodiesterase activity: effect of yessotoxin on
cAMP levels in human lymphocytes. Biochem. Pharmacol. 65, 193–208.
Alfonso, C., Alfonso, A., Vieytes, M.R., Yasumoto, T., Botana, L.M., 2005.
Quantiﬁcation of yessotoxin using the ﬂuorescence polarization technique, and
study of the adequate extraccion procedure. Anal. Biochem. 344, 266–274.
Bottomley, S.S., Wolfe, L.C., Bridges, K.R., 1985. Iron metabolism in
K562 erythroleukemic cells. J. Biol. Chem. 260, 6811–6815.
Codogno, P., Meijer, A.J., 2005. Autophagy and signaling: their role in cell survival
and cell death. Cell Death Differ. 12, 1509–1518.
Copsel, S., Garcia, C., Diez, F., Vermeulem, M., Baldi, A., Bianciotti, L.G., Russel, F.G.,
Shayo, C., Davio, C., 2011. Multidrug resistance protein 4 (MRP4/ABCC4)
regulates cAMP cellular levels and controls human leukemia cell proliferation
and differentiation. J. Biol. Chem. 286, 6979–6988.
Chen, Z.H., Lam, H.C., Jin, Y., Kim, H.P., Cao, J., Lee, S.J., Ifedigbo, E., Parameswaran, H.,
Ryter, S.W., Choi, A.M., 2010. Autophagy proteinmicrotubule-associated protein
1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-
induced emphysema. Proc. Natl. Acad. Sci. U. S. A. 107, 18880–18885.
Cherra, S.J., Kulich, S.M., Uechi, G., Balasubramani, M., Mountzouris, J., Day, B.W.,
Chu, C.T., 2010. Regulation of the autophagy protein LC3 by phosphorylation. J.
Cell. Biol. 190, 533–539.
Christian, F., Anthony, D.F., Vadrevu, S., Riddell, T., Day, J.P., McLeod, R., Adams, D.R.,
Baillie, G.S., Houslay, M.D., 2010. p62 (SQSTM1) and cyclic AMP
phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate
with links to autophagy and proteasome degradation pathways. Cell Signal. 22,
1576–1596.
Daniels, T.R., Delgado, T., Helguera, G., Penichet, M.L., 2006. The transferrin receptor
part II: targeted delivery of therapeutic agents into cancer cells. Clin. Immunol.
121, 159–176.
Day, J.P., Lindsay, B., Riddell, T., Jiang, Z., Allcock, R.W., Abraham, A., Sookup, S.,
Christian, F., Bogum, J., Martin, E.K., Rae, R.L., Anthony, D., Rosair, G.M., Houslay,
D.M., Huston, E., Baillie, G.S., Klussmann, E., Houslay, M.D., Adams, D.R., 2011.
Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-
dependent intracellular redistribution of cAMP phosphodiesterase-4A4
(PDE4A4). J. Med. Chem. 54, 3331–3347.
Di Pietro, R., di Giacomo, V., Caravatta, L., Sancilio, S., Rana, R.A., Cataldi, A., 2007.
Cyclic nucleotide response element binding (CREB) protein activation is
involved in K562 erythroleukemia cells differentiation. J. Cell. Biochem. 100,
1070–1079.
Fernández-Araujo, A., Tobío, A., Alfonso, A., Botana, L.M., 2014. Role of AKAP
149–PKA–PDE4A complex in cell survival and cell differentiation processes. Int
J. Biochem. Cell Biol. 53, 89–101.
Gatter, K.C., Brown, G., Trowbridge, I.S.,Woolston, R.E.,Mason, D.Y.,1983. Transferrin
receptors in human tissues: their distribution and possible clinical relevance. J.
Clin. Pathol. 36 (5), 539–545.
Harootunian, A.T., Adams, S.R., Wen, W., Meinkoth, J.L., Taylor, S.S., Tsien, R.Y., 1993.
Movement of the free catalytic subunit of cAMP-dependent protein kinase into
and out of the nucleus can be explained by diffusion. Mol. Biol. Cell 4, 993–1002.
Honma, Y., Okabe-Kado, J., Hozumi, M., Uehara, Y., Mizuno, S., 1989. Induction of
erythroid differentiation of K562 human leukemic cells by herbimycin A: an
inhibitor of tyrosine kinase activity. Cancer Res. 49, 331–334.
Huang, H.L., Chen, Y.C., Huang, Y.C., Yang, K.C., Pan, H., Shih, S.P., Chen, Y.J., 2011.
Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in
chronic myelogenous leukemia K562 cells. PLoS One 6, e29014.
Jambal, P., Masterson, S., Nesterova, A., Bouchard, R., Bergman, B., Hutton, J.C., Boxer,
L.M., Reusch, J.E., Pugazhenthi, S., 2003. Cytokine-mediated down-regulation of
the transcription factor cAMP-response element-binding protein in pancreatic
beta-cells. J. Biol. Chem. 278, 23055–23065.
Joassard, O.R., Amirouche, A., Gallot, Y.S., Desgeorges, M.M., Castells, J., Durieux, A.C.,
Berthon, P., Freyssenet, D.G., 2013. Regulation of Akt-mTOR: ubiquitin–
proteasome and autophagy–lysosome pathways in response to formoterol
administration in rat skeletal muscle. Int. J. Biochem. Cell Biol. 45, 2444–2455.
Kasibhatla, S., Jessen, K.A., Maliartchouk, S., Wang, J.Y., English, N.M., Drewe, J., Qiu,
L., Archer, S.P., Ponce, A.E., Sirisoma, N., Jiang, S., Zhang, H.Z., Gehlsen, K.R., Cai, S.
X., Green, D.R., Tseng, B., 2005. A role for transferrin receptor in triggering
apoptosis when targeted with gambogic acid. Proc. Natl. Acad. Sci. U. S. A. 102,
12095–12100.
Khan, M.I., Mohammad, A., Patil, G., Naqvi, S.A., Chauhan, L.K., Ahmad, I., 2012.
Induction of ROS, mitochondrial damage and autophagy in lung epithelial
cancer cells by iron oxide nanoparticles. Biomaterials 33, 1477–1488.
Kimmelman, A.C., 2011. The dynamic nature of autophagy in cancer. Genes Dev. 25,
1999–2010.
Klionsky, D.J., Emr, S.D., 2000. Autophagy as a regulated pathway of cellular
degradation. Science 290, 1717–1721.
Kondo, Y., Kanzawa, T., Sawaya, R., Kondo, S., 2005. The role of autophagy in cancer
development and response to therapy. Nat. Rev. Cancer 5, 726–734.
Korsnes, M.S., 2012. Yessotoxin as a tool to study induction of multiple cell death
pathways. Toxins 4, 568–579.
Korsnes, M.S., Espenes, A., 2011. Yessotoxin as an apoptotic inducer. Toxicon 57,
947–958.
Kotamraju, S., Chitambar, C.R., Kalivendi, S.V., Joseph, J., Kalyanaraman, B., 2002.
Oxidative stress-induced iron signaling is responsible for peroxide-dependent
oxidation of dichlorodihydroﬂuorescein in endothelial cells. Role of transferrin
receptor-dependent iron uptake. J. Biol. Chem. 277 (19), 17179–17187.
Kurz, T., Terman, A., Gustafsson, B., Brunk, U.T., 2008. Lysosomes in ironmetabolism,
ageing and apoptosis. Histochem. Cell Biol. 129, 389–406.
Kurz, T., Eaton, J.W., Brunk, U.T., 2011. The role of lysosomes in iron metabolism and
recycling. Int. J. Biochem. Cell Biol. 43, 1686–1697.
Lawen, A., Ly, J.D., Lane, D.J.R., Zarschler, K., Messina, A., Pinto, V.D., 2005. Voltage-
dependent anion-selective channel 1 (VDAC1)—a mitochondrial protein:
rediscovered as a novel enzyme in the plasma membrane. Int. J. Biochem. Cell
Biol. 37, 277–282.
Lazova, R., Camp, R.L., Klump, V., Siddiqui, S.F., Amaravadi, R.K., Pawelek, J.M., 2012.
Punctate LC3B expression is a common feature of solid tumors and associated
with proliferation metastasis and poor outcome. Clin. Cancer Res. 18, 370–379.
Lira, E.C., Goncalves, D.A., Parreiras-E-Silva, L.T., Zanon, N.M., Kettelhut, I.C.,
Navegantes, L.C., 2011. Phosphodiesterase-4 inhibition reduces proteolysis and
atrogenes expression in rat skeletal muscles. Muscle Nerve 44, 371–381.
Liu, Y., Su, Y., Wang, J., Sun, S., Wang, T., Qiao, X., Run, X., Li, H., Liang, Z., 2013.
Rapamycin decreases tau phosphorylation at Ser214 through regulation of
cAMP-dependent kinase. Neurochem. Int. 62, 458–467.
Marsee, D.K., Pinkus, G.S., Yu, H., 2010. CD71 (transferrin receptor): an effective
marker for erythroid precursors in bone marrow biopsy specimens. Am. J. Clin.
Pathol. 134 (3), 429–435.
Mavrakis, M., Lippincott-Schwartz, J., Stratakis, C.A., Bossis, I., 2006. Depletion of
type IA regulatory subunit (RIa) of protein kinase A (PKA) in mammalian cells
and tissues activates mTOR and causes autophagic deﬁciency. Human Mol.
Genet. 15, 2962–2971.
Mei, Y., Yin, N., Jin, X., He, J., Yin, Z., 2013. The regulatory role of the adrenergic
agonists phenylephrine and isoproterenol on fetal hemoglobin expression and
erythroid differentiation. Endocrinology 154, 4640–4649.
Murata, M., Kumagai, M., Lee, J.S., Yasumoto, T., 1987. Isolation and structure of
yessotoxin, a novel polyether compound implicated in diarrhetic shellﬁsh
poisoning. Tetrahedron Lett. 28, 5869–5872.
Ohyashiki, J.H., Kobayashi, C., Hamamura, R., Okabe, S., Tauchi, T., Ohyashiki, K.,
2009. The oral iron chelator deferasirox represses signaling through the mTOR
in myeloid leukemia cells by enhancing expression of REDD1. Cancer Sci. 100,
970–977.
A. Fernández-Araujo et al. / Toxicology 329 (2015) 60–72 71
Osti, F., Corradini, F.G., Hanau, S., Matteuzzi, M., Gambari, R., 1997. Human leukemia
K562 cells: induction to erythroid differentiation by guanine, guanosine and
guanine nucleotides. Haematologica 82, 395–401.
Pankiv, S., Lamark, T., Bruun, J.A., Overvatn, A., Bjorkoy, G., Johansen, T., 2010.
Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of
nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J. Biol.
Chem. 285, 5941–5953.
Pellegrini, M., Cheng, J.C., Voutila, J., Judelson, D., Taylor, J., Nelson, S.F., Sakamoto, K.
M., 2008. Expressionproﬁle of CREB knockdown inmyeloid leukemia cells. BMC
Cancer 8, 264.
Ponkaa, P., Lok, C.N., 1999. The transferrin receptor: role in health and disease. Int. J.
Biochem. Cell Biol. 31, 1111–1137.
Ren, J.G., Seth, P., Everett, P., Clish, C.B., Sukhatme, V.P., 2010. Induction of erythroid
differentiation in human erythroleukemia cells by depletion of malic enzyme 2.
PLoS One 5.
Rowley, P.T., Ohlsson-Wilhelm, B.M., Farley, B.A., LaBella, S., 1981. Inducers of
erythroid differentiation of KS62 human leukemia cells. Exp. Hematol. 9 (1),
32–37.
Rubiolo, J.A., López-Alonso,H.,Martínez, P.,Millán,A., Cagide, E., Vieytes,M.R., Vega, F.
V., Botana, L.M., 2014. Yessotoxin induces ER-stress followed by autophagic cell
death in glioma cells mediated by mTOR and BNIP3. Cell. Signal. 26, 419–432.
Ryschich, E., Huszty, G., Knaebel, H.P., Hartel, M., Büchler, M.W., Schmidt, J., 2004.
Transferrin receptor is a marker of malignant phenotype in human pancreatic
cancer and in neuroendocrine carcinoma of the pancreas. Eur. J. Cancer 40,
1418–1422.
Salazar, G., Gonzalez, A., 2002. Novelmechanism for regulation of epidermal growth
factor receptor endocytosis revealed by protein kinase A inhibition. Mol. Biol.
Cell 13, 1677–1693.
Sample, V., DiPilato, L.M., Yang, J.H., Ni, Q., Saucerman, J.J., Zhang, J., 2012. Regulation
of nuclear PKA revealed by spatiotemporal manipulation of cyclic AMP. Nat.
Chem. Biol. 8, 375–382.
Satake, M., MacKenzie, L., Yasumoto, T., 1997. Identiﬁcation of protoceratium
reticulatum as the biogenetic origin of yessotoxin. Nat. Toxins 5, 164–167.
Shaywitz, A.J., Greenberg, M.E., 1999. CREB: a stimulus-induced transcription factor
activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68,
821–861.
Stern, S.T., Adiseshaiah, P.P., Crist, R.M., 2012. Autophagy and lysosomal dysfunction
as emerging mechanisms of nanomaterial toxicity. Particle Fibre Toxicol. 9, 20.
Tampo, Y., Kotamraju, S., Chitambar, C.R., Kalivendi, S.V., Keszler, A., Joseph, J.,
Kalyanaraman, B., 2003. Oxidative stress-induced iron signaling is responsible
for peroxide-dependent oxidation of dichlorodihydroﬂuorescein in endothelial
cells. Circ. Res. 92, 56–63.
Tobío, A., Alfonso, A., Botana, L.M., 2011. C-kit mutations and PKC crosstalks PKC
translocates to nucleous only in cells HMC 560,816. J. Cell. Biochem. 112,
2637–2651.
Tobío, A., Fernández-Araujo, A., Alfonso, A., Botana, L.M., 2012. Role of yessotoxin in
calcium and cAMP-crosstalks in primary and K-562 human lymphocytes: the
effect is mediated by anchor kinase a mitochondrial proteins. J. Cell. Biochem.
113, 3752–3761.
Tobío, A., Alfonso, A., Fernández-Araujo, A., Alonso, E., Botana, L.M., 2013. Protein
kinase C modulates aurora-kinase inhibition induced by CCT129202 in HMC-
1560816 cell line. Anti-Inﬂam. Anti-Allergy Agents Med. Chem. 12, 265–276.
Tsiftsoglou, A.S., Pappas, I.S., Vizirianakis, I.S., 2003. Mechanisms involved in the
induced differentiation of leukemia cells. Pharmacol. Ther. 100, 257–290.
Vassaux, G., Gaillard, D., Ailhaud, G., Négrel, R., 1992. Prostacyclin is a speciﬁc
effector of adipose cell differentiation. Its dual role as a cAMP- and Ca(2
+)-elevating agent. J. Biol. Chem. 267, 11092–11097.
Walss, C., Kreisberg, J.I., Ludueña, R.F., 1999. Presence of the bII isotype of tubulin in
the nuclei of cultured mesangial cells from rat kidney. Cell Motil. Cytoskeleton
42, 274–284.
Wang, M., Crager, M., Pugazhenthi, S., 2012. Modulation of apoptosis pathways by
oxidative stress and autophagy in beta cells. Exp. Diabetes Res. 2012, 647914.
Wu, J., Dang, Y., Su, W., Liu, C., Ma, H., Shan, Y., Pei, Y., Wan, B., Guo, J., Yu, L., 2006.
Molecular cloning and characterization of rat LC3A and LC3B—two novel
markers of autophagosome. Biochem. Biophys. Res. Commun. 339, 437–442.
Wu, X.R., Xue, M., Li, X.F., Wang, Y., Wang, J., Han, Q.L., Yi, Z.C., 2011. Phenolic
metabolites of benzene inhibited the erythroid differentiation of K562 cells.
Toxicol. Lett. 203, 190–199.
Yang, Y., Yang, L., You, Q.D., Nie, F.F., Gu, H.Y., Zhao, L., Wang, X.T., Guo, Q.L., 2007.
Differential apoptotic induction of gambogic acid a novel anticancer natural
product on hepatoma cells and normal hepatocytes. Cancer Lett. 256, 259–266.
Yu, L., Alva, A., Su, H., Dutt, P., Freundt, E., Welsh, S., Baehrecke, E.H., Lenardo, M.J.,
2004. Regulation of an ATG7-beclin 1 program of autophagic cell death by
caspase-8. Science 304, 1500–1502.
72 A. Fernández-Araujo et al. / Toxicology 329 (2015) 60–72
